Chromomycin A3

Template:Chembox image cellTemplate:Chembox AllOtherNamesTemplate:Chembox headerbarTemplate:Chembox IndexlistTemplate:Chembox JmolTemplate:Chembox ChEMBLTemplate:Chembox ECHATemplate:Chembox E numberTemplate:Chembox IUPHAR ligandTemplate:Chembox UNIITemplate:Chembox CompToxTemplate:Chembox headerbarTemplate:Chembox Datapage checkTemplate:Chembox Footer

Chromomycin A3

Template:Longitem	Template:Unbulleted list
ChEBI	Template:Unbulleted list
ChemSpider	Template:Unbulleted list
DrugBank	Template:Unbulleted list
EC Number	Template:Unbulleted list
KEGG	Template:Unbulleted list
Template:Longitem	Template:Unbulleted list
RTECS number	Template:Unbulleted list
Template:Longitem	Template:Chembox Elements/molecular formula
Molar mass	Template:Chem molar mass

Chromomycin A3 (CMA₃) or Toyomycin is an anthraquinone antibiotic glycoside produced by the fermentation of a certain strain of Streptomyces griseus (No. 7).

Fluorescence properties

In the presence of Mg²⁺ ions, Chromomycin A₃ binds reversibly to DNA, preferentially to contiguous G/C base pairs.

When bound to DNA, Chromomycin A₃ has a maximum excitation wavelength of 445 nm (blue), and a maximum emission wavelength of 575 nm (yellow).

Uses

• in-vitro membrane-impermeant G/C-specific fluorescent DNA-binding dye.
• in-vitro antibiotic of gram-positive bacteria, through inhibition of the incorporation of P_i in the RNA.
• in-vitro anticancer drug that inhibits RNA synthesis.
• Evaluation of male fertility: Chromomycin A₃ and protamines compete for the same binding sites in the DNA, so CMA₃ positivity in spermatozoa reflects protamine deficiency (affecting sperm morphology and decreasing fertility).